InAADR

Drug Information

Drug Name: Prothipendyl (303-69-5)
PubChem ID: 14670
SMILES: CN(C)CCCN1C2=CC=CC=C2SC3=C1N=CC=C3
InchiKey: JTTAUPUMOLRVRA-UHFFFAOYSA-N
Therapeutic Category:

Computed Drug Properties

Molecular Weight (dalton): 285.416
LogP: 3.636
Ring Count: 2
Hydrogen Bond Acceptor Count: 4
Hydrogen Bond Donor Count: 0
Total Polar Surface Area: 19.37

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abdominal Adhesions MetaADEDB
Abnormal Vision MetaADEDB
Abscess MetaADEDB
Abuse MetaADEDB
Acidosis MetaADEDB
Acute Brain Syndrome MetaADEDB
Acute Myocardial Infarction MetaADEDB
Acute Psychosis MetaADEDB
Adh Inappropriate MetaADEDB
Afib MetaADEDB
Agitated MetaADEDB
Altered State Of Consciousness MetaADEDB
Alveolitis MetaADEDB
Amnesia MetaADEDB
Anaphylactic Reaction MetaADEDB
Anticholinergic Syndrome MetaADEDB
Arrhythmia Supraventricular MetaADEDB
Arterial Pressure Nos Decreased MetaADEDB
Ataxia MetaADEDB
Atrial Ectopic Beats MetaADEDB
Attempted Suicide MetaADEDB
Bladder Inflammation MetaADEDB
Blood Calcium MetaADEDB
Blood Count Abnormal MetaADEDB
Blood Creatinine Increased MetaADEDB
Blood Potassium Decreased MetaADEDB
Blood Sodium MetaADEDB
Blood Thyroid Stimulating Hormone MetaADEDB
Bone Marrow Disorder MetaADEDB
Bradypnoea MetaADEDB
C-Reactive Protein Increased MetaADEDB
Cancer MetaADEDB
Cardiogenic Shock MetaADEDB
Cartilage Development Disorder MetaADEDB
Causalgia MetaADEDB
Cerebral Disorder MetaADEDB
Cerebral Haemorrhage MetaADEDB
Cerebral Vascular Disorder MetaADEDB
Clonus MetaADEDB
Coma MetaADEDB
Concomitant Disease Progression MetaADEDB
Confabulation MetaADEDB
Death MetaADEDB
Depigmentation MetaADEDB
Dizziness MetaADEDB
Dizziness Exertional MetaADEDB
Drowsiness MetaADEDB
Drug Interaction MetaADEDB
Dysthymic Disorder MetaADEDB
Electrocardiogram Qt Prolonged MetaADEDB
Electrolyte Disorder MetaADEDB
Electrophoresis Protein Abnormal MetaADEDB
Elevated Erythrocyte Sedimentation Rate MetaADEDB
Elevated Triglycerides MetaADEDB
Embolism MetaADEDB
Embolism Pulmonary MetaADEDB
Escherichia Infection MetaADEDB
Fistula MetaADEDB
Fluid Intake Reduced MetaADEDB
Galactorrhea MetaADEDB
Gastroenteritis Norovirus MetaADEDB
Gastrointestinal Obstruction MetaADEDB
General Physical Health Deterioration MetaADEDB
Heart Rate Increased MetaADEDB
Hepatic Enzyme MetaADEDB
Hepatocellular Damage MetaADEDB
Hodgkin Disease MetaADEDB
Hospitalisation MetaADEDB
Hypercapnia MetaADEDB
Hypokalaemia MetaADEDB
Hypomania MetaADEDB
Intra-Abdominal Haemorrhage MetaADEDB
Lung Infiltration MetaADEDB
Lymphocyte Morphology Abnormal MetaADEDB
Lymphoma MetaADEDB
Multiple Drug Overdose MetaADEDB
Multiple Drug Overdose Intentional MetaADEDB
Off Label Use MetaADEDB
Oropharyngeal Spasm MetaADEDB
Overdose MetaADEDB
Parkinson MetaADEDB
Pedal Pulse Absent MetaADEDB
Perianal Abscess MetaADEDB
Psychoses MetaADEDB
Ruptured Cerebral Aneurysm MetaADEDB
Somatoform Disorder MetaADEDB
Sopor MetaADEDB
Status Epilepticus MetaADEDB
Sternal Fracture MetaADEDB
Stress Cardiomyopathy MetaADEDB
Subcutaneous Abscess MetaADEDB
Sudden Cardiac Death MetaADEDB
Tongue Spasm MetaADEDB
Urine Output Increased MetaADEDB
Uterine Cancer MetaADEDB
Varicose Vein MetaADEDB
Ventricular Fibrillation MetaADEDB

InAADR: Drug-Protein-ADRs database